Rapid Dose Therapeutics Corp. (CSE:DOSE)
Canada · Delayed Price · Currency is CAD 0.1000
0.00 (0.00%)
Oct 9, 2026, 3:46 PM EST
Rapid Dose Therapeutics Market Cap
Rapid Dose Therapeutics has a market cap or net worth of CAD 13.78 million as of October 9, 2026. It is the 41,872nd most valuable company in the world and the 1,479th biggest in Canada. Its market cap has decreased by 40.74% in one year.
Market Cap
13.78M
Enterprise Value
19.57M
Revenue
2.58M
Global Rank
Country Rank
#1,479 Canada
PE Ratio
n/a
ChartMarket Cap Chart
Since December 17, 2018, Rapid Dose Therapeutics's market cap has decreased from 63.77M to 13.78M, a decrease of -78.39%. That is a compound annual growth rate of -17.80%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 13.78M | -21.94% |
| Dec 31, 2025 | 17.65M | -37.53% |
| Dec 31, 2024 | 28.26M | 63.18% |
| Dec 29, 2023 | 17.32M | -67.57% |
| Dec 31, 2021 | 53.40M | 110.14% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 17, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Pharmala Biotech Holdings | 23.58M |
| Devonian Health Group | 22.94M |
| Onco-Innovations | 22.15M |
| Lobe Sciences | 20.37M |
| Alzai Health | 20.09M |
| Hemostemix | 15.86M |
| Britannia Life Sciences | 10.70M |
| Rakovina Therapeutics | 10.03M |